Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Clinical trial NCT01970501 · COMPLETED
Trial details
- NCT number
- NCT01970501
- Sponsor
- ARCA Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-12-28
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.